News

Glenmark, SaNOtize launch FabiSpray in India

FabiSpray will be used to treat adult patients with COVID-19 in partnership with SaNOtize

Glenmark Pharmaceuticals and Canadian pharmaceutical company SaNOtize Research & Development Corp announced the launch of its Nitric Oxide Nasal Spray under the brand name FabiSpray in India; for the treatment of adult patients with COVID-19 who have a high risk of progression of the disease. 

THIS CAN BE YOUR ADVERTISEMENT

Glenmark earlier received manufacturing and marketing approval from the Drugs Controller General of India (DCGI) for NONS as part of the accelerated approval process.

Support us in our endeavor to bring you Advertisement free content.
Choose your options to donate or subscribe.

Tags

Related Articles

Back to top button
Close
Close